Heterocyclic modulators of lipid synthesis
US-2024400552-A1 · Dec 5, 2024 · US
US10815214B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10815214-B2 |
| Application number | US-201916576133-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 19, 2019 |
| Priority date | Dec 7, 2012 |
| Publication date | Oct 27, 2020 |
| Grant date | Oct 27, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A novel process is provided for the efficient preparation of an asymmetric compound of structural formula I: comprising a copper-catalyzed, carbon-nitrogen cross-coupling step. The process described as part of the present invention can be used to manufacture poly (ADP-ribose) polymerase (PARP) inhibitors, which may be useful for the treatment of cancer. In particular, the present invention describes a process for the manufacture of the PARP inhibitor, 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide.
Opening claim text (preview).
What is claimed is: 1. A compound of formula IV: wherein: R 1 is C 4-8 alkyl, C 3-10 cycloalkyl, C 4-10 heterocyclyl, aryl, or heteroaryl; and R 2 is an amine protecting group. 2. The compound of claim 1 , wherein R 1 is t-butyl, cumyl, or trityl. 3. The compound of claim 1 , wherein the amine protecting group is selected from the group consisting of formyl, acetyl, trifluoroacetyl, benzyl, benzoyl, carbamate, benzyloxycarbonyl, p-methoxybenzyl carbonyl, tert-butoxycarbonyl, trimethylsilyl, 2-trimethylsilyl-ethanesulfonyl, trityl, substituted trityl groups, allyloxycarbonyl, 9-fluorenylmethyloxycarbonyl, nitro-veratryloxycarbonyl, p-methoxybenzyl, and tosyl. 4. The compound of claim 1 , wherein the amine protecting group is tert-butoxycarbonyl. 5. The compound of claim 2 , wherein the amine protecting group is selected from the group consisting of formyl, acetyl, trifluoroacetyl, benzyl, benzoyl, carbamate, benzyloxycarbonyl, p-methoxybenzyl carbonyl, tert-butoxycarbonyl, trimethylsilyl, 2-trimethylsilyl-ethanesulfonyl, trityl, substituted trityl groups, allyloxycarbonyl, 9-fluorenylmethyloxycarbonyl, nitro-veratryloxycarbonyl, p-methoxybenzyl, and tosyl. 6. The compound of claim 2 , wherein the amine protecting group is tert-butoxycarbonyl. 7. The compound of claim 1 , wherein R 1 is t-butyl and R 2 is tert-butoxycarbonyl, which is (S)-tert-butyl 3 -(4-(7-(tert-butylcarbamoyl)-2H-indazol-2-yl)phenyl)piperidine- 1-carboxylate: 8. The compound of claim 1 , wherein R 1 is cumyl and R 2 is tert-butoxycarbonyl, which is (S)-tert-butyl 3 -(4-(7-((2-phenylpropan-2-yl)carbmoyl)-2H-indazol-2-yl)phenyl)piperidine- 1-carboxyl ate:
linked by a carbon chain containing aromatic rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.